BBHC
CDNA icon

Brown Brothers Harriman & Co’s CareDx CDNA Stock Holding History

Brown Brothers Harriman & Co’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-216
Closed -$2.46K – 1274
2022
Q4 		$2.46K Hold
216
– – ﹤0.01% 1154
2022
Q3 		$4K Hold
216
– – ﹤0.01% 1327
2022
Q2 		$5K Buy
+216
New +$5.99K ﹤0.01% 1139

Other funds holding CDNA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Brown Brothers Harriman & Co's CDNA Position: Q1 2023 in Review

Brown Brothers Harriman & Co sold out of CareDx (CDNA) in Q1 2023, closing a stake of 216 shares — an estimated $2.46K sold.

Brown Brothers Harriman & Co first reported a position in CDNA in Q2 2022 and held it in 3 quarters. The position peaked at $5K in Q2 2022. 156 funds tracked by Wall St. Rank hold CDNA as of Q1 2023.

  • Brown Brothers Harriman & Co reported no remaining CareDx position as of Q1 2023 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 216 CareDx shares in Q1 2023, an estimated $2.46K.
  • Brown Brothers Harriman & Co first reported a position in CareDx in Q2 2022 and held it in 3 quarters.
  • Brown Brothers Harriman & Co's CareDx position peaked at $5K in Q2 2022.
  • 156 funds tracked by Wall St. Rank held CareDx as of Q1 2023.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2023, filed 11 May 2023.